Number of the records: 1
heparín s nízkou molekulovou hmotnosťou
SYS d006495 LBL 00000cz--a2200000n--4500 005 20250606213454.3 008 920325|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D09.698.373.400.300 066 $a 01 $c 03 150 $a heparín s nízkou molekulovou hmotnosťou $x AA $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $2 slo 450 $w v $a LMWH $2 eng 450 $w v $a Low-Molecular-Weight Heparin $2 eng 450 $w v $a LMWH $2 slo 450 $w v $a heparín nízkomolekulový $2 slo 550 $7 sllk_us_auth*d000925 $Y Anticoagulants $w P $a antikoagulanciá 550 $7 sllk_us_auth*d005343 $Y Fibrinolytic Agents $w P $a fibrinolytiká 665 $a 94; was ENOXAPARIN 1992-93, was HEPARIN, LOW MOLECULAR WEIGHT 1988-91; HEPARIN, LOW MOLECULAR WEIGHT was see ENOXAPARIN 1992-93; LOW-MOLECULAR-WEIGHT HEPARIN was LOW MOLECULAR WEIGHT HEPARIN 1988-93 $2 eng 665 $a Heparin (1966-1987) $2 eng 680 9-
$i Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. $2 eng 680 $a /antag = probably HEPARIN ANTAGONISTS $2 eng 750 -2
$a Heparin, Low-Molecular-Weight $2 eng 980 $x M
Number of the records: 1